Cardiac JAK2 mutation V617F in a patient with cardiomyopathy and myeloproliferative disease

Annals of Internal Medicine

Volumn 149, Issue 1, 2008, Pages 69-71

  Gattenlohner, Stefan ^a   Ertl, Georg ^a   Einsele, Hermann ^a   Kircher, Stefan ^a   Muller Hermelink, Hans Konrad ^a   Marx, Alexander ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2; STAT3 PROTEIN;

ADULT; AUTOPSY; CARDIOMEGALY; CARDIOMYOPATHY; CASE REPORT; FEMALE; GENE MUTATION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOCYTOCHEMISTRY; LETTER; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; SPLENECTOMY; SPLENOMEGALY; THROMBOCYTHEMIA; WESTERN BLOTTING;

EID: 46449093620     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-149-1-200807010-00027     Document Type: Letter

References (6)

1. Tefferi A, Lasho TL, Gilliland G. JAK2 mutations in myeloproliferative disorders [Letter]. N Engl J Med. 2005;353:1416-7; author reply 1416-7. [PMID: 16192494]
2. Jurgens DJ, Moreno-Aspitia A, Tefferi A. Anagrelide-associated cardiomyopathy in polycythemia vera and essential thrombocythemia [Letter]. Haematologica. 2004;89: 1394-5. [PMID: 15531464]
3. Booz GW, Day JN, Baker KM. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart feilure. J Mol Cell Cardiol. 2002;34:1443-53. [PMID: 12431443]
4. Gunsilius E, Duba HC, Petzer AL, Kähler CM, Grünewald K, Stockhammer G, et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet. 2000;355:1688-91. [PMID: 10905245]
5. Serafini M, Dylla SJ, Oki M, Heremans Y, Tolar J, Jiang Y, et al. Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells. J Exp Med. 2007;204:129-39. [PMID: 17227908]
6. Passamonti F, Vanelli L, Malabarba L, Rumi E, Pungolino E, Malcovati L, et al. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. Haematologica. 2003;88:1123-9. [PMID: 14555308]